Heterogeneous molecular behavior in liver tumors (HCC and CCA) of two patients with acute intermittent porphyria-Reference-Cited by-同舟云学术

Heterogeneous molecular behavior in liver tumors (HCC and CCA) of two patients with acute intermittent porphyria

Published:2022-10-16 Issue:6 Volume:149 Page:2647-2655
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Haverkamp Thomas,Bronisch Olivia,Knösel Thomas,Mogler Carolin,Weichert Wilko,Stauch Thomas,Schmid Claudia,Rummeny Claudia,Beykirch Maria K.,Petrides Petro E.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-022-04384-5.pdf

Reference28 articles.

1. Baumann K, Kauppinen R (2022) Long-term follow up of acute porphyria in female patients: update of clinical outcome and life expectancy. Mol Genet Metab Rep. 30:100842

2. Bronisch O, Stauch T, Haverkamp T, Beykirch MK, Petrides PE (2019) Acute porphyrias: a German monocentric study of the biochemical, molecular genetic and clinical data of 62 families. Ann Hematol 98:2683–2691

3. Chong DQ, Zhu AX (2016) The landscape of targeted therapies for cholangio-carcinoma: current status and emerging targets. Oncotarget 7:46750–46767

4. Ding X, Zhu Q-G, Zhang S-M et al (2017) Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy. Oncotarget 8:55715–55730

5. Douki T, Onuki J, Medeiros MH et al (1998) DNA alkylation by 4,5-dioxovaleric acid, the final oxidation product of 5-aminolevulinic aci. Chem Res Toxicol 11:150–157

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver transplantation and primary liver cancer in porphyria;Liver International;2024-03-08

2. Nanoparticles drug delivery for 5-aminolevulinic acid (5-ALA) in photodynamic therapy (PDT) for multiple cancer treatment: a critical review on biosynthesis, detection, and therapeutic applications;Journal of Cancer Research and Clinical Oncology;2023-09-30

3. Intrahepatic Cholangiocarcinoma and Acute Intermittent Porphyria: A Case Report;Journal of Clinical Medicine;2023-04-24